David Tu, president of DCL, looks at the tremendous pressures that logistics providers and their customers are facing, as they balance traditional distribution and direct-to-consumer services.

Laurel Junk, vice president of supply chain with Kaiser Permanente, details the transformation that's under way in the hospital industry, driven by healthcare reform and a new focus on the ultimate "customer" - the patient.

Lower-cost "biosimilars" are coming to the U.S. Gillian Woollett, chief scientist with Engel & Novitt LLP, discusses the implications for drug companies, supply-chain managers and patients.

Jim Burleigh, chief executive officer of SmartTurn, talks about the challenges faced by small and medium-sized companies in a time of tight budgets, slow demand and stricter government regulations.